Ar-Ge gideri · 2025 mali yılı
| 1 | MerckMRK | $15,8B |
|---|---|---|
| 2 | AstraZenecaAZN | $14,2B |
| 3 | Eli LillyLLY | $13,3B |
| 4 | PfizerPFE | $10,4B |
| 5 | Bristol Myers SquibbBMY | $10,0B |
| 6 | GSKGSK | $9,9B |
| 7 | AbbVieABBV | $9,1B |
| 8 | Novo Nordisk A SNVO | $7,9B |
| 9 | AmgenAMGN | $7,3B |
| 10 | Regeneron PharmaceuticalsREGN | $5,9B |